Factor Information
Data ID 200
Factor Pulmonary vascular resistance index (PVRI) at baseline
Description pulmonary vascular resistance (PVR) < 6.65 Wood units (WU)/m2 indicated a good prognosis after surgical correction with an area under the curve (AUC) of 98.3% (95% confidence interval [CI]: 96.0–100%), sensitivity of 100%, and specificity of 82.1%
Biomarker YES
Classification E10 (physiological factor - other)
Association
Application prognosis
Objective evaluated the predictors and prognoses of children with PAH-CHD who underwent surgical correction.
p Value <0.001
Conclusion Although the criteria for positive AVT currently used are unsuitable for pediatric patients with PAH-CHD, PVR and PVR/SVR during AVT are excellent predictors of outcome in pediatric PAH-CHD. Surgery aided by anti-PAH drugs is an effective strategy and should be recommended for severe pediatric PAH-CHD with PVR ≤ 6.65WU/m2 and PVR/SVR ≤ 0.39 after iloprost aerosol inhalation.
Risk Factor unknown
CHD Type
ID 426
CHD Type isolated CHD/non-isolated CHD
CHD Subtype VSD/ASD/PDA/APSD/VSD, PDA/ASD, PDA/ASD, VSD/AVSD/PAH
Reference
PMID 30789367
Year 2019
Title Predictors of operability in children with severe pulmonary hypertension associated with congenital heart disease.
Sample
Population children
Source Guangzhou, China
Region Guangzhou, China
Method A regression analysis, receiver-operating characteristic (ROC) curves, and Kaplan-Meier curves were used for survival analysis.
Race Asian
Disease History N/A
Treatment History heart catheterization and correction, with or without specific anti- PAH drugs postoperatively,
Group favorable PAH-CHD(Treatment) unfavorable PAH-CHD(Control)
Number 42 14
Age 6.5 (3.8–13.2) years 9 (7.1–14.2) years
Gender (Male: Female) 20:22 6:8
Marker Level 4.9 (3.5–5.9) (WU/m2) 10.8 (9.1–14.8) (WU/m2)